Similar articles

Abstract: ObjectivesIn this study, we explored how adiponectin mediated urotensin II (UII)‍-induced tumor necrosis factor-‍α(TNF-‍α) andα‍-smooth muscle actin (α‍-SMA) expression and ensuing intracellular signaling pathways in adventitial fibroblasts (AFs).
MethodsGrowth-arrested AFs and rat tunica adventitia of vessels were incubated with UII and inhibitors of signal transduction pathways for 1‍‒‍24 h. The cells were then harvested for TNF-αreceptor (TNF-‍α-R) messenger RNA (mRNA) and TNF-‍αprotein expression determination by reverse transcription-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA), respectively. adiponectin and adiponectin receptor (adipoR) expression was measured by RT-PCR, quantitative real-time PCR (qPCR), immunohistochemical analysis, and cell counting kit-8 (CCK-8) cell proliferation experiments. We then quantified TNF-α and α-SMA mRNA and protein expression levels by qPCR and immunofluorescence (IF) staining. RNA interference (RNAi) was used to explore the function of the adipoR genes. To investigate the signaling pathway, we applied western blotting (WB) to examine phosphorylation of adenosine 5'-monophosphate (AMP)‍-activated protein kinase (AMPK). In vivo, an adiponectin (APN)‍-knockout (APN-KO) mouse model mimicking adventitial inflammation was generated to measure TNF-α and α‍-SMA expression by application of qPCR and IF, with the goal of gaining a comprehensive atlas of adiponectin in vascular remodeling.
ResultsIn both cells and tissues, UII promoted TNF-α protein and TNF-α-R secretion in a dose- and time-dependent manner via Rho/protein kinase C (PKC) pathway. We detected marked expression of adipoR1, T-cadherin, and calreticulin as well as a moderate presence of adipoR2 in AFs, while no adiponectin was observed. Globular adiponectin (gAd) fostered the growth of AFs, and acted in concert with UII to induce α-SMA and TNF-α through the adipoR1/T-cadherin/calreticulin/AMPK pathway. In AFs, gAd and UII synergistically induced AMPK phosphorylation. In the adventitial inflammation model, APN deficiency up-regulated the expression of α-SMA, UII receptor (UT), and UII while inhibiting TNF-‍αexpression.
ConclusionsFrom the results of our study, we can speculate that UII induces TNF‍-‍αprotein and TNF-‍α‍-R secretion in AFs and rat tunica adventitia of vessels via the Rho and PKC signal transduction pathways. Thus, it is plausible that adiponectin is a major player in adventitial progression and could serve as a novel therapeutic target for cardiovascular disease administration.

球型脂联素对尾加压素II诱导血管外膜分泌肿瘤坏死因子介导血管重构的影响

[1]AmesRS, SarauHM, ChambersJK, et al., 1999. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature, 401(6750):282-286.

[2]AvagimyanA, KajaiaA, GabuniaL, et al., 2022. Urotensin-II as a promising key-point of cardiovascular disturbances sequel. Curr Probl Cardiol, 47(11):101074.

[3]BobbertP, AntoniakS, SchultheissHP, et al., 2008. Globular adiponectin but not full-length adiponectin induces increased procoagulability in human endothelial cells. J Mol Cell Cardiol, 44(2):388-394.

[4]DongX, YeXJ, SongNN, et al., 2013. Urotensin II promotes the production of LTC₄ in rat aortic adventitial fibroblasts through NF-κB-5-LO pathway by p38 MAPK and ERK activations. Heart Vessels, 28(4):514-523.

[5]EnzerinkA, VaheriA, 2011. Fibroblast activation in vascular inflammation. J Thromb Haemost, 9(4):619-626.

[6]EvansBR, YerlyA, van der VorstEPC, et al., 2022. Inflammatory mediators in atherosclerotic vascular remodeling. Front Cardiovasc Med, 9:868934.

[7]HassanGS, DouglasSA, OhlsteinEH, et al., 2005. Expression of urotensin-II in human coronary atherosclerosis. Peptides, 26(12):2464-2472.

[8]LauWB, OhashiK, WangYJ, et al., 2017. Role of adipokines in cardiovascular disease. Circ J, 81(7):920-928.

[9]LiAC, GlassCK, 2002. The macrophage foam cell as a target for therapeutic intervention. Nat Med, 8(11):1235-1242.

[10]LiuLH, ShiZH, JiXH, et al., 2022. Adipokines, adiposity, and atherosclerosis. Cell Mol Life Sci, 79(5):272.

[11]LuD, PengF, LiJ, et al., 2019. Urotensin II promotes secretion of LTB4 through 5-lipoxygenase via the UT-ROS-Akt pathway in RAW264.7 macrophages. Arch Med Sci, 15(4):1065-1072.

[12]NosalskiR, GuzikTJ, 2017. Perivascular adipose tissue inflammation in vascular disease. Br J Pharmacol, 174(20):3496-3513.

[13]ParkSL, LeeBK, KimYA, et al., 2013. Inhibitory effect of an urotensin II receptor antagonist on proinflammatory activation induced by urotensin II in human vascular endothelial cells. Biomol Ther (Seoul), 21(4):277-283.

[14]Pereira-CastroJ, Brás-SilvaC, Fontes-SousaAP, 2019. Novel insights into the role of urotensin II in cardiovascular disease. Drug Discov Today, 24(11):2170-2180.

[15]RamiAZA, HamidAA, AnuarNNM, et al., 2022. Exploring the relationship of perivascular adipose tissue inflammation and the development of vascular pathologies. Mediators Inflamm, 2022:2734321.

[16]RuanH, DongLQ, 2016. Adiponectin signaling and function in insulin target tissues. J Mol Cell Biol, 8(2):101-109.

[17]SowkaA, DobrzynP, 2021. Role of perivascular adipose tissue-derived adiponectin in vascular homeostasis. Cells, 10(6):1485.

[18]StenmarkKR, YeagerME, el KasmiKC, et al., 2013. The adventitia: essential regulator of vascular wall structure and function. Annu Rev Physiol, 75:23-47.

[19]TinajeroMG, GotliebAI, 2020. Recent developments in vascular adventitial pathobiology: the dynamic adventitia as a complex regulator of vascular disease. Am J Pathol, 190(3):520-534.

[20]von der ThüsenJH, van BerkelTJC, BiessenEAL, 2001. Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation, 103(8):1164-1170.

[21]WangZV, SchererPE, 2016. Adiponectin, the past two decades. J Mol Cell Biol, 8(2):93-100.

[22]WatsonAMD, OlukmanM, KoulisC, et al., 2013. Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes. Diabetologia, 56(5):1155-1165.

[23]YamauchiT, KamonJ, ItoY, et al., 2003. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 423(6941):762-769.

[24]ZhangR, WuJ, LiuD, et al., 2013. Anti-inflammatory effect of full-length adiponectin and proinflammatory effect of globular adiponectin in esophageal adenocarcinoma cells. Oncol Res, 21(1):15-21.

[25]ZhangYG, LiYG, WeiRH, et al., 2008a. Urotensin II is an autocrine/paracrine growth factor for aortic adventitia of rat. Regul Pept, 151(1-3):88-94.

[26]ZhangYG, LiJ, LiYG, et al., 2008b. Urotensin II induces phenotypic differentiation, migration, and collagen synthesis of adventitial fibroblasts from rat aorta. J Hypertens, 26(6):1119-1126.

[27]ZhangYG, HuYC, MaoYY, et al., 2010. Transforming growth factor-β1 involved in urotensin II-induced phenotypic differentiation of adventitial fibroblasts from rat aorta. Chin Med J (Engl), 123(24):3634-3639.

[28]ZhangYG, BaoSL, KuangZJ, et al., 2014. Urotensin II promotes monocyte chemoattractant protein-1 expression in aortic adventitial fibroblasts of rat. Chin Med J (Engl), 127(10):1907-1912.

[29]ZhaoK, YangCX, LiP, et al., 2020. Epigenetic role of N⁶-methyladenosine (m⁶A) RNA methylation in the cardiovascular system. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 21(7):509-523.

[30]ZhaoK, ZhangJ, XuTH, et al., 2021. Low-intensity pulsed ultrasound ameliorates angiotensin II-induced cardiac fibrosis by alleviating inflammation via a caveolin-1-dependent pathway. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 22(10):818-838.

[31]ZhouX, LiJQ, WeiLJ, et al., 2020. Silencing of DsbA-L gene impairs the PPARγ agonist function of improving insulin resistance in a high-glucose cell model. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 21(12):‍990-998.